American Diabetes Association

Skip to Main Content

Table 2—

Prevalence of metabolic syndrome in patients with and without complications

	Type 1 diabetes					Type 2 diabetes
		n	Metabolic syndrome			n	Metabolic syndrome
		n		Absent (%)	Present (%)	n		Absent (%)	Present (%)
AHA/NHLBI metabolic syndrome
Complication
None	322	76.4	23.6	4,211	34.7	65.3
Retinopathy	218	58.3	41.7	1,732	24.7	75.3
Neuropathy	123	51.2	48.8	1,115	24.5	75.5
Nephropathy	172	48.3	51.7	1,777	21.7	78.3
Cardiovascular	59	45.8	54.2	1,302	23.3	76.7
IDF metabolic syndrome
Complication
None	322	70.8	29.2	4,211	26.9	73.1
Retinopathy	218	49.5	50.5	1,732	17.2	82.8
Neuropathy	123	44.7	55.3	1,115	18.2	81.8
Nephropathy	172	40.1	59.9	1,777	14.9	85.1
Cardiovascular	59	35.6	64.4	1,302	14.6	85.4

	Type 1 diabetes					Type 2 diabetes
		n	Metabolic syndrome			n	Metabolic syndrome
		n		Absent (%)	Present (%)	n		Absent (%)	Present (%)
AHA/NHLBI metabolic syndrome
Complication
None	322	76.4	23.6	4,211	34.7	65.3
Retinopathy	218	58.3	41.7	1,732	24.7	75.3
Neuropathy	123	51.2	48.8	1,115	24.5	75.5
Nephropathy	172	48.3	51.7	1,777	21.7	78.3
Cardiovascular	59	45.8	54.2	1,302	23.3	76.7
IDF metabolic syndrome
Complication
None	322	70.8	29.2	4,211	26.9	73.1
Retinopathy	218	49.5	50.5	1,732	17.2	82.8
Neuropathy	123	44.7	55.3	1,115	18.2	81.8
Nephropathy	172	40.1	59.9	1,777	14.9	85.1
Cardiovascular	59	35.6	64.4	1,302	14.6	85.4

Total diagnosed according AHA/NHLBI and IDF criteria: type 1 diabetic patients n = 638, type 2 diabetic patients n = 7,859.